KRAS and cancer: We have already reported that the KRAS-G12C clone was addicted to glutamine to grow and proliferate [23], so the accumulation of the two main players in the glutaminolysis pathway (glutamine and glutamate) indicates that the PI3K inhibitors interfered with the principal energy source for this cancer cell clone.